Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program
Alleviant Medical, Inc., a privately held medical device company developing a no-implant atrial shunt for heart failure, today announced a $90 million financing to fund its second pivotal trial. Led by Gilde Healthcare, the round also...
14. Januar 2025